SCPH icon

scPharmaceuticals

59 hedge funds and large institutions have $152M invested in scPharmaceuticals in 2022 Q4 according to their latest regulatory filings, with 25 funds opening new positions, 21 increasing their positions, 8 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
59
Holders Change
+19
Holders Change %
+47.5%
% of All Funds
0.95%
Holding in Top 10
3
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+200%
% of All Funds
0.05%
New
25
Increased
21
Reduced
8
Closed
6
Calls
$302K
Puts
$693K
Net Calls
-$391K
Net Calls Change
-$440K
Name Holding Trade Value Shares
Change
Shares
Change %
DWA
51
Dorsey Wright & Associates
California
$23.7K +$23.7K +3,300 New
UBS Group
52
UBS Group
Switzerland
$22.2K +$22.2K +3,090 New
Group One Trading
53
Group One Trading
Illinois
$10.4K -$184K -25,616 -95%
Bank of America
54
Bank of America
North Carolina
$7.37K +$201 +28 +3%
Fidelity Investments
55
Fidelity Investments
Massachusetts
$5.13K
Citigroup
56
Citigroup
New York
$1.86K +$1.86K +260 New
Dimensional Fund Advisors
57
Dimensional Fund Advisors
Texas
$1.54K +$546 +76,119 +55%
BNP Paribas Financial Markets
58
BNP Paribas Financial Markets
France
$760
Wells Fargo
59
Wells Fargo
California
$466 +$7 +1 +2%
IC
60
Ikarian Capital
Texas
-$3.13M -479,383 Closed
Belvedere Trading
61
Belvedere Trading
Illinois
-$661K -120,706 Closed
Wolverine Trading
62
Wolverine Trading
Illinois
-$141K -23,282 Closed
RWM
63
Ritholtz Wealth Management
New York
-$98K -15,000 Closed
Envestnet Asset Management
64
Envestnet Asset Management
Illinois
-$92K -14,186 Closed